Skip to content
Peptigraph home

Tesamorelin for Muscle Growth: What the Evidence Shows

What human and animal studies show about Tesamorelin for muscle growth, how strong that evidence is, and what is still unproven.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureGHRH analogUpdated
Strongest evidence
None graded
no study with an outcome for muscle growth (PubMed search, 11 Oct 2026)
Human studies
None found
with an outcome for muscle growth, in our evidence file (PubMed search, 11 Oct 2026)
Animal studies
None found
with an outcome for muscle growth, in our evidence file (PubMed search, 11 Oct 2026)

Evidence for muscle growth

None of the study abstracts we summarised for Tesamorelin reported an outcome for muscle growth (PubMed search, 11 Oct 2026). Claims that it helps with muscle growth are unproven.

How strong is it?

Strongest evidence:No graded study for muscle growth (PubMed search, 11 Oct 2026)

A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.

Muscle in context

MedlinePlus says muscle disorders can cause weakness, pain or even paralysis.[4]

What the trials measured for muscle and lean mass

In HIV patients with a clinically significant drop in visceral fat on tesamorelin, skeletal muscle area and density rose.[5]

In a trial of GHRH treatment in adults with mild cognitive impairment and healthy older adults, IGF-1 rose by 117% and percent body fat fell by 7.4%. The abstract gives no lean mass figure.[6]

The label lists lean body mass among the other endpoints of its pivotal studies.[7]

The Egrifta WR label describes its effect on weight as neutral.[7]

Bodybuilding searches and anti-doping

WADA's prohibited list names tesamorelin among the GHRH analogues.[8]

Other peptides people research for muscle growth

All peptides for muscle growth, compared

Common questions

Does Tesamorelin help with muscle growth?

None of the studies we summarised for Tesamorelin (PubMed search, 11 Oct 2026) measured an outcome for muscle growth. Treat claims that it helps with muscle growth as unproven.

Is Tesamorelin approved for muscle growth?

Tesamorelin is FDA approved (Egrifta). Which conditions that approval covers is set by the label; use for anything else is off-label.

What is the best peptide for muscle growth?

There is no single answer. Our muscle growth overview compares each candidate by evidence grade and legal status rather than by popularity.

Does tesamorelin build muscle?

In one analysis of HIV patients, those with a clinically significant fall in visceral fat also had rises in skeletal muscle area and density.[5]

Is Egrifta used for bodybuilding?

No bodybuilding study is cited here. WADA's list names tesamorelin among the GHRH analogues.[8]

Does tesamorelin increase IGF-1?

Yes. In the first phase 3 trial IGF-I rose 81.0% on tesamorelin and fell 5.0% on placebo.[9]

More on Tesamorelin

Sources

  1. 1PubMed search: (tesamorelin[tiab] OR Egrifta[tiab] OR TH9507[tiab] OR "TH-9507"[tiab]) (104 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  2. 2PubMed search: (tesamorelin[tiab] OR TH9507[tiab]) AND (pharmacokinetic*[tiab] OR half-life[tiab]) (5 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  3. 3PubMed search: (tesamorelin[tiab] OR Egrifta[tiab] OR TH9507[tiab] OR "TH-9507"[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (36 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
  4. 4medlineplus.gov pagemedlineplus.gov · web pagemedlineplus.gov
  5. 5The Growth Hormone Releasing Hormone Analogue, Tesamorelin, Decreases Muscle Fat and Increases Muscle Area in Adults with HIV.The Journal of frailty & aging · 2019PMID 31237318Accessed 2 Oct 2026
  6. 6Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial.Archives of neurology · 2012PMID 22869065Accessed 2 Oct 2026
  7. 7EGRIFTA WR prescribing information (FDA label)FDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
  8. 8World Anti-Doping Code International Standard Prohibited List 2026 (in effect 1 January 2026)World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
  9. 9Metabolic effects of a growth hormone-releasing factor in patients with HIV.The New England journal of medicine · 2007PMID 18057338Accessed 2 Oct 2026

Found an error? Report a correction.